Company intelligence / Profile preview

Steinmetz Advisory Group

Bryn Mawr, Pennsylvania, United Stateslinkedin.com ↗

Ownership: Private
Development stage: Other

Overview

Steinmetz Advisory Group is a consulting firm specializing in the development and commercialization of oncology products. The group provides strategic guidance to pre-commercial stage oncology companies, supporting projects ranging from IND-stage assets to market access strategy and execution for phase III and launch-stage products.

Therapeutic areas: Oncology
Modalities: Not directly applicable (consulting firm, not a drug developer)
Industry: Consulting

Partnerships

Works with various pre-commercial stage oncology companies as clients

Beyond the preview

Go deeper on Steinmetz Advisory Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Steinmetz Advisory Group.

Explore the full profile